VANECK ETF TRUST - BIOTECH ETF (BBH)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / BIOTECH ETF
Total 13F shares
631
Share change
+631
Total reported value
$104,311
Price per share
$165.31
Number of holders
1
Value change
+$104,311
Number of buys
1

Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2023

As of 31 Dec 2023, VANECK ETF TRUST - BIOTECH ETF (BBH) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 631 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, Miller Investment Management, LP, JPMORGAN CHASE & CO, MORGAN STANLEY, COMMONWEALTH EQUITY SERVICES, LLC, Consolidated Investment Group LLC, ROYAL BANK OF CANADA, UBS Group AG, and LPL Financial LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.